Clinical Case
A previously healthy 62-year-old man was admitted to the intensive care unit with acute heart failure and pancytopenia. Serum protein electrophoresis demonstrated an elevated IgM paraprotein level of 31 g/L. Bone marrow biopsy confirmed mature B-cell lymphocytosis with an immunophenotype of CD20+, CD10À, CD5À and a focal increase in CD138. A diagnosis of Waldenstr€ om's macroglobulinemia was established. His presentation was complicated by markedly elevated levels of serum calcium and lactate dehydrogenase, suggesting transformation of his hematological disorder. Cardiac magnetic resonance (CMR) imaging revealed biventricular hypertrophy with patchy delayed enhancement (DE) throughout the left ventricular myocardium, which was highly suspicious of cardiac amyloidosis (Fig. 1A-C) . A fat pad biopsy was negative for Congo red staining but confirmed CD20+ and CD10-diffuse large B-cell lymphoma (DLBCL) ( Fig. 1D and E). Promptly after the diagnosis of DLBCL, he was initiated on chemotherapy consisting of rituximab, cyclophosphamide, etoposide, vincristine, and prednisone. He received a total of six cycles of chemotherapy over the course of 6 months. End-of-therapy monoclonal immunoglobulin concentration declined from 31 to 5 g/L, and positron emission tomography confirmed no residual active metabolic disease. Repeat CMR imaging demonstrated complete resolution of both the infiltrative disease and biventricular hypertrophy (Fig. 1F-H) .
Cardiac lymphoma is a rare clinical diagnosis with DLBCL accounting for 42% of all cases [1] . By contrast, cardiac involvement is common in AL amyloidosis and occurs in about 50% of cases [2] . Cardiac amyloidosis characteristically appears as diffuse patchy enhancement on DE-CMR [3] . Our case highlights that cardiac lymphoma may mimic amyloid infiltration of the myocardium on CMR, and is a particularly challenging diagnosis in the setting of transformed Waldenstr€ om's macroglobulinemia. Heightened clinical suspicion and early diagnosis of cardiac lymphoma using CMR is paramount as chemotherapy has been demonstrated to portent an increased survival rate [1] .
Authorship LL, VM, IDCK, DSJ, and RK: contributed to the writing and approval of the final manuscript. 
